PhRMA Warns Tariffs Won’t Boost U.S. Drug Manufacturing, Cites Global Trade Benefits

By Maaisha Osman / May 7, 2025 at 7:06 PM

Pharmaceutical Research and Manufacturers of America (PhRMA), the leading brand-name drug lobby, is urging the Department of Commerce to steer clear of tariffs as a strategy to boost domestic drug manufacturing.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.